[What phase IV should be like for an anxiolytic agent].

The phase IV of an anxiolytic preparation comprises all studies done after marketing. Specialized complementary studies allow to better define psychopharmacological profile: reaction to provoked stress, anxiolytic and sedative components, correlation blood levels - clinical effects, studies in elderly patients, mixed anxiety-depression syndromes. Surveillance studies are aimed to detect as soon as possible rare and serious adverse reactions.